SPECIAL NOTICE
R -- Scientific Content of a Strategic Plan in Response to the Combating Autism Act of 2006
- Notice Date
- 1/12/2009
- Notice Type
- Special Notice
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, Maryland, 20892
- ZIP Code
- 20892
- Solicitation Number
- 888200
- Archive Date
- 2/10/2009
- Point of Contact
- Jasmine D Snoddy,, Phone: 301 594 1571
- E-Mail Address
-
snoddyj@mail.nih.gov
- Small Business Set-Aside
- Total Small Business
- Description
- This is a notice of intent, not a request for a proposal. A solicitation document will not be issued and proposals will not be requested. The National Institute on Drug Abuse on behalf of the National Institute of Mental Health (NIMH) intends to negotiate, evaluate, and award a purchase order on a sole source basis to Stephen Foote, Ph.D., to develop the scientific content of NIMH’s Strategic Plan in response to the Combating Autism Act of 2006. Dr. Foote has extensive leadership experience broadly in neuroscience, and specifically in the area of autism. Dr. Foote has coordinated numerous autism research activities within NIH, across federal agencies, and in government partnerships with non-governmental organizations. Dr. Foote has had great success implementing much of the autism-related mandates of the Children’s Health Act of 2000. For example, in response to the Children’s Health Act, Dr. Foote was responsible for establishing a temporary advisory committee, which joined DHHS, other agencies and departments as well. Dr. Foote has testified to Congress repeatedly on autism research issues that remain contentious and are still important focal points for NIH interactions with the advocacy community. Additionally, Dr. Foote led the implementation of the congressionally mandated STAART centers program, which has a direct counterpart in the Combating Autism Act. Dr. Foote, will lead discussions with the Federal Advisory Committee and draft the scientific content of the strategic plan for the NIMH. The acquisition is being conducted under simplified acquisition using FAR 13 procedures and is exempt from the requirements of FAR Part 6, Competition Requirement. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely with the discretion of the Government. Comments to this announcement, referencing synopsis number 888200 may be submitted to the NIDA, Station Support/Simplified Acquisition Branch, 31 Center Drive, Bldg 31, Room 1B59, Bethesda, MD 20892-2080, and Attention: Jasmine Snoddy, Contract Specialist.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=e1cb152a0bbc382fc38ab0c977159586&tab=core&_cview=1)
- Place of Performance
- Address: Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN01731010-W 20090114/090112215720-e1cb152a0bbc382fc38ab0c977159586 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |